Controversy: the essence of medical debate

Stroke. 2003 Feb;34(2):372-3. doi: 10.1161/01.str.0000054670.86396.96.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anticoagulants / therapeutic use
  • Clinical Trials as Topic / standards
  • Fibrinolytic Agents / adverse effects*
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Magnetic Resonance Imaging
  • Patient Selection
  • Research Design
  • Risk Assessment
  • Stroke / diagnosis
  • Stroke / therapy*
  • Thrombolytic Therapy / adverse effects
  • Time Factors
  • Tissue Plasminogen Activator / adverse effects
  • Tissue Plasminogen Activator / therapeutic use
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Tissue Plasminogen Activator